These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 23687287

  • 1. Oral antiretroviral drugs as public health tools for HIV prevention: global implications for adherence, drug resistance, and the success of HIV treatment programs.
    Gupta RK, Wainberg MA, Brun-Vezinet F, Gatell JM, Albert J, Sönnerborg A, Nachega JB.
    J Infect Dis; 2013 Jun 15; 207 Suppl 2(Suppl 2):S101-6. PubMed ID: 23687287
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Concentrations of tenofovir and emtricitabine in saliva: implications for preexposure prophylaxis of oral HIV acquisition.
    de Lastours V, Fonsart J, Burlacu R, Gourmel B, Molina JM.
    Antimicrob Agents Chemother; 2011 Oct 15; 55(10):4905-7. PubMed ID: 21788466
    [Abstract] [Full Text] [Related]

  • 4. Evaluating the extent of potential resistance to pre-exposure prophylaxis within the UK HIV-1-infectious population of men who have sex with men.
    Dolling D, Phillips AN, Delpech V, Pillay D, Cane PA, Crook AM, Shepherd J, Fearnhill E, Hill T, Dunn D, UK HIV Drug Resistance Database, UK Collaborative HIV Cohort (UK CHIC) Study.
    HIV Med; 2012 May 15; 13(5):309-14. PubMed ID: 22151684
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. HIV preexposure prophylaxis: new data and potential use.
    Celum CL.
    Top Antivir Med; 2011 Dec 15; 19(5):181-5. PubMed ID: 22298887
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Oral antiretroviral chemoprophylaxis: current status.
    Baeten J, Celum C.
    Curr Opin HIV AIDS; 2012 Nov 15; 7(6):514-9. PubMed ID: 22964886
    [Abstract] [Full Text] [Related]

  • 11. Tenofovir-based preexposure prophylaxis for HIV infection among African women.
    Marrazzo JM, Ramjee G, Richardson BA, Gomez K, Mgodi N, Nair G, Palanee T, Nakabiito C, van der Straten A, Noguchi L, Hendrix CW, Dai JY, Ganesh S, Mkhize B, Taljaard M, Parikh UM, Piper J, Mâsse B, Grossman C, Rooney J, Schwartz JL, Watts H, Marzinke MA, Hillier SL, McGowan IM, Chirenje ZM, VOICE Study Team.
    N Engl J Med; 2015 Feb 05; 372(6):509-18. PubMed ID: 25651245
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Pre-exposure prophylaxis for the prevention of sexual HIV transmission; new preventative strategy using tenofovir/emtricitabine].
    Boot J, Rump BO, Boucher CA, Op de Coul EL, van Agtmael MA, van de Vijver DA, Burger DM, Fanoy EB.
    Ned Tijdschr Geneeskd; 2013 Feb 05; 157(27):A6063. PubMed ID: 23838402
    [Abstract] [Full Text] [Related]

  • 17. [Pre-exposure prophylaxis for HIV transmission? No, unless].
    Boeke AJ, Heijnen AM.
    Ned Tijdschr Geneeskd; 2013 Feb 05; 157(27):A6359. PubMed ID: 23838404
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers.
    Mutua G, Sanders E, Mugo P, Anzala O, Haberer JE, Bangsberg D, Barin B, Rooney JF, Mark D, Chetty P, Fast P, Priddy FH.
    PLoS One; 2012 Feb 05; 7(4):e33103. PubMed ID: 22511916
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.